Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Gross Profit: 2009-2025

Historic Gross Profit for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $188.1 million.

  • BIO-TECHNE's Gross Profit rose 2.78% to $188.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $795.4 million, marking a year-over-year increase of 3.62%. This contributed to the annual value of $790.3 million for FY2025, which is 2.67% up from last year.
  • BIO-TECHNE's Gross Profit amounted to $188.1 million in Q3 2025, which was down 5.38% from $198.8 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Gross Profit high stood at $214.6 million for Q1 2025, and its period low was $168.3 million during Q1 2021.
  • In the last 3 years, BIO-TECHNE's Gross Profit had a median value of $198.8 million in 2025 and averaged $195.9 million.
  • In the last 5 years, BIO-TECHNE's Gross Profit soared by 55.27% in 2021 and then dropped by 3.69% in 2023.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Gross Profit stood at $183.7 million in 2021, then dropped by 0.18% to $183.4 million in 2022, then declined by 3.69% to $176.6 million in 2023, then rose by 9.80% to $193.9 million in 2024, then increased by 2.78% to $188.1 million in 2025.
  • Its last three reported values are $188.1 million in Q3 2025, $198.8 million for Q2 2025, and $214.6 million during Q1 2025.